B, Sept. 28, 2017 -- Marine Corps General John “Jay” Paxton Jr. (Ret) has joined the Council of Directors of The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF).
|
||||||||
He served as the 33rd Assistant Commandant of the Marine Corps before retiring in 2016. As the second-highest ranking officer in the Marine Corps, he played a critical role in ensuring the health and wellbeing of Marines. With deployments to locations worldwide, he emphasized, advocated and recommended priorities for the Marine Corps.
“General Paxton is an incredibly accomplished individual with a genuine commitment to the health and readiness of America’s fighting force,” said Philip Odeen, chairman of HJF’s Council of Directors. “We are very fortunate in bringing his expertise and experience to our board. He is a most welcome addition.”
General Paxton received the Hero of Military Medicine Senior Leader Award from HJF in 2016 for his commitment to delivering world-class medical care to Marines and for his extraordinary contribution to improving the lives of U.S. service members, veterans and their families. General Paxton’s wife, Debbie Paxton, R.N., M.S.N., F.N.P., was honored with a Hero of Military Medicine Civilian Award in 2015 for her work as mental health advisor to the U.S. Marine Corps Wounded Warrior Regiment, where she engaged the military and civilian medical communities in the treatment of traumatic brain injury and posttraumatic stress. The Hero of Military Medicine Awards are presented each May by HJF and its Center for Public-Private Partnerships.
The Foundation, a private, not-for-profit organization, serves its mission of advancing research and education at the Uniformed Services University of the Health Sciences and throughout the military medical community.
It offers services that allow military researchers and clinicians to maintain their scientific focus and accomplish their research goals. HJF recruits staff, establishes and manages laboratories and research programs, administers clinical trials, and facilitates the transfer of technology to the private sector.
HJF supports hundreds of research projects, ranging from small bench-top projects to complex, multi-site programs. Its extensive research portfolio includes cancer, combat casualty care, infectious disease and precision medicine. One of its most important roles is facilitating clinical trials of vaccines for diseases that can affect our service members, including HIV, malaria and Ebola.
* * *
About HJF
HJF is one of the largest private, not-for-profit organizations in the Washington, D.C. area. It was established in 1983 and authorized by the U.S. Congress to support medical research and education at the Uniformed Services University of the Health Sciences and throughout the military community. The Foundation is headquartered in Bethesda, Maryland, but operates across the U.S. and internationally. www.hjf.org.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/38944c15-6fe1-4183-9d1a-e8b187276a7e
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/2c4f7308-79a5-446d-b8c7-b6e2ff52c696
JoAnn Sperber Henry M. Jackson Foundation for the Advancement of Military Medicine 240-694-2163 [email protected]


Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 



